Objective To detect plasma concentrations of Calcitonin gene-related peptide (CGRP),endothelin (ET)-1 at different periods after subarachnoid hemorrhage(SAH),and probe the correlation of CGRP,ET-1 and the pathogenesis of cerebral vasospasm after SAH.Mehods Plasma concentrations of CGRP,ET-1 were measured in patients who were diagnosed with SAH (38 cases) at different periods (1-3 d,4-7 d,14-21 d after SAH) by radio-immunity technique.According to the occurrence of cerebral vasospasm,these patients were separated into two groups:vasospasm group(31 cases) and non-vasospasm group(7 cases).Twenty healthy persons after physical examinations were allocated to be control group.Results Compared with control group and nin-vasospasm group,the plasma concentration of CGRP in vasospasm group was obviously lower,especially in the 4-7 d time slot,and ET-1 was obviously higher,especially in the 4-7 d time slot.There were statistical differences among the three groups(P<0.05 or <0.01).Cerebral vasospasm occurred in 2 cases during 1-3 d,in 28 cases during 4-7 d and in l case during 14-2l d after SAH.Conclusions CGRP,ET-1 participate in the pathological process of SAH.The abnormality of vascular endnfhelial construction/diastolic function is correlated with delayed cerebral vasospasm.

Background and purpose:Breast cancer is one of the most common malignant diseases in women and its malignant proliferation is the major cause of death. To investigate the effects of N-myc downstream regulated gene 2 (NDRG2) on proliferation of breast cancer cells by using two parallel cell lines (MCF-7 and LM-MCF-7) with different metastatic abilities.Methods:The expression level of NDRG2 in breast cancer cells was detected by Western blot. The effects of overexpressing (or down-regulating) NDRG2 on proliferation of breast cancer cells were investigat-ed by lfow cytometry. The expression and location of β-catenin were detected by Western blot and immunolfuorescence respectively. NDRG2 blocking the transcription activity of β-catenin was investigated via co-transfecting MCF-7 cells with NDRG2 siRNA and pCMV-Tcfδ (lacking the portion responsible for the protein binding to DNA).Results:The expression level of NDRG2 was negatively related to the proliferation ability of breast cancer cells. Over-expressing NDRG2 (or down-regulating) via transfecting LM-MCF-7 (or MCF-7) cells with pCMV-NDRG2 (or NDRG2 siRNA) could inhibit (or promote) cell proliferation. Interestingly, the results of Western blot, immunolfuorescence and lfow cytometry revealed that down-regulation of NDRG2 resulted from the down-regulation of β-catenin and blocking its nuclear translocation, which led to losing control of the proliferation of breast cancer cells.Conclusion:NDRG2 inhibit the proliferation of breast cancer cells via down-regulating the expression of β-catenin and blocking its nuclear translo-cation, which is signiifcant for exploring the molecular mechanism of proliferation of breast cancer cells.